concept

SYNUCLEINOPATHY

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SYNUCLEINOPATHY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

475Connections

0Hypotheses

5Analyses

50Outgoing

50Incoming

0Experiments

5Debates

Summary

SYNUCLEINOPATHY is a concept in neurodegeneration research. Key relationships include: activates, associated with, therapeutic target. Associated with Aging, Als, Alzheimer. Connected to 118 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	SYNUCLEINOPATHY
Key Genes/Proteins	ACHE, AGING, ALPHA-SYNUCLEIN, ALZHEIMER, ALZHEIMER'S DISEASE, AMYLOID
Related Diseases	Aging, Als, ALS, Alzheimer, Anxiety
Related Pathways	Alpha-Synuclein, Amyloid

Wiki Pages (1)

Knowledge base pages for this entity

Synucleinopathy Mechanism

mechanism · 4870 words

Pathway Diagram

graph TD
    SYNUCLEINOPATHY["SYNUCLEINOPATHY"]
    SYNUCLEINOPATHY -->|"inhibits"| Synucleinopathy["Synucleinopathy"]
    SYNUCLEINOPATHY -->|"activates"| Neurodegeneration["Neurodegeneration"]
    SYNUCLEINOPATHY -->|"inhibits"| Tauopathy["Tauopathy"]
    SYNUCLEINOPATHY -->|"activates"| Autophagy["Autophagy"]
    SYNUCLEINOPATHY -->|"activates"| Phagocytosis["Phagocytosis"]
    SYNUCLEINOPATHY -->|"activates"| Immune_Response["Immune Response"]
    SYNUCLEINOPATHY -->|"activates"| ASTROCYTE["ASTROCYTE"]
    SYNUCLEINOPATHY -->|"inhibits"| ALPHA_SYNUCLEIN["ALPHA-SYNUCLEIN"]
    SYNUCLEINOPATHY -->|"inhibits"| TAU["TAU"]
    SYNUCLEINOPATHY -->|"activates"| AMYLOID_BETA["AMYLOID-BETA"]
    BMAL1["BMAL1"] -->|"inhibits"| SYNUCLEINOPATHY
    BAG3["BAG3"] -->|"activates"| SYNUCLEINOPATHY
    CLOCK["CLOCK"] -->|"activates"| SYNUCLEINOPATHY
    TFR1["TFR1"] -->|"activates"| SYNUCLEINOPATHY
    GPX4["GPX4"] -->|"activates"| SYNUCLEINOPATHY
    MLKL["MLKL"] -->|"activates"| SYNUCLEINOPATHY
    RIPK3["RIPK3"] -->|"activates"| SYNUCLEINOPATHY
    GENES["GENES"] -->|"activates"| SYNUCLEINOPATHY
    CTSD["CTSD"] -->|"activates"| SYNUCLEINOPATHY
    SNCA["SNCA"] -->|"activates"| SYNUCLEINOPATHY

Outgoing (212)

Target	Relation	Type	Str
Als	causes	disease	0.75
Synucleinopathy	therapeutic_target	disease	0.75
Parkinson	associated_with	disease	0.75
Neurodegeneration	activates	disease	0.75
Parkinson	activates	disease	0.75
Neurodegeneration	causes	disease	0.75
Synucleinopathy	associated_with	disease	0.75
Synucleinopathy	activates	disease	0.75
Neurodegeneration	phosphorylates	disease	0.65
Ataxia	inhibits	disease	0.65
Als	inhibits	disease	0.65
Ms	inhibits	disease	0.65
Neuroinflammation	regulates	disease	0.65
Inflammation	regulates	disease	0.65
Parkinson	phosphorylates	disease	0.65
Parkinson	regulates	disease	0.65
Neuroinflammation	associated_with	disease	0.65
Als	expressed_in	disease	0.65
Neurodegeneration	regulates	disease	0.65
Inflammation	associated_with	disease	0.65
Synucleinopathy	causes	disease	0.65
Neurodegeneration	expressed_in	disease	0.65
Neuroinflammation	inhibits	disease	0.65
Aging	inhibits	disease	0.65
Inflammation	inhibits	disease	0.65
Senescence	inhibits	disease	0.65
Neurodegeneration	causes	disease	0.65
Ms	regulates	disease	0.65
Synucleinopathy	regulates	disease	0.65
ALS	activates	disease	0.65
Neurodegeneration	associated_with	disease	0.65
Synucleinopathy	inhibits	disease	0.65
Alzheimer	associated_with	disease	0.65
Dementia	associated_with	disease	0.65
Neurodegeneration	therapeutic_target	disease	0.65
Als	associated_with	disease	0.65
Synucleinopathy	expressed_in	disease	0.65
Ms	therapeutic_target	disease	0.65
Tauopathy	inhibits	disease	0.65
Parkinson	inhibits	disease	0.65
Parkinson	causes	disease	0.65
Parkinson	activates	disease	0.65
Tauopathy	activates	disease	0.65
Neuroinflammation	activates	disease	0.65
Inflammation	activates	disease	0.65
Alzheimer	causes	disease	0.65
Aging	associated_with	disease	0.65
Ms	activates	disease	0.65
Neurodegeneration	inhibits	disease	0.65
Huntington	associated_with	disease	0.65

Incoming (263)

Source	Relation	Type	Str
SNCA	associated_with	gene	0.90
PARKINSON'S DISEASE	activates	gene	0.85
PARKINSON	activates	gene	0.75
SYNUCLEINOPATHY	therapeutic_target	gene	0.75
SYNUCLEINOPATHY	activates	gene	0.75
NEUROINFLAMMATION	activates	gene	0.75
Parkinson	associated_with	disease	0.75
PARKINSON	associated_with	gene	0.75
PARKINSON'S DISEASE	associated_with	gene	0.75
NEURODEGENERATION	activates	gene	0.75
NEURODEGENERATION	causes	gene	0.75
ALPHA-SYNUCLEIN	activates	gene	0.75
NEURODEGENERATIVE DISEASES	activates	gene	0.75
SYNUCLEINOPATHY	associated_with	gene	0.75
SNCA	causes	gene	0.70
TNF-α	associated_with	protein	0.70
Hsp70 inducer + Hsp90 inhibitor	synergizes	drug	0.70
PARKINSON'S DISEASE	associated_with	gene	0.70
PARKINSON	associated_with	gene	0.70
SCFAS	regulates	drug	0.70
NEURODEGENERATION	activates	gene	0.70
ALPHA-SYNUCLEIN	activates	gene	0.70
PARKINSON'S DISEASE	activates	gene	0.70
PARKINSON	activates	gene	0.70
STING	associated_with	gene	0.65
AUTOPHAGY	activates	gene	0.65
DNA	associated_with	gene	0.65
GPX4	activates	gene	0.65
PARKINSON	causes	gene	0.65
GENES	activates	gene	0.65
TMEM175	associated_with	gene	0.65
BMAL1	inhibits	gene	0.65
INPP5F	associated_with	gene	0.65
SNCA-AS1	associated_with	gene	0.65
TFR1	activates	gene	0.65
TAU	inhibits	gene	0.65
ALZHEIMER	causes	gene	0.65
SCARB2	associated_with	gene	0.65
GBA	associated_with	gene	0.65
CLOCK	activates	gene	0.65
GAN	therapeutic_target	gene	0.65
NF-ΚB	therapeutic_target	gene	0.65
PHAGOCYTOSIS	activates	gene	0.65
AMYLOID	activates	gene	0.65
ASTROCYTES	activates	gene	0.65
TAU PATHOLOGY	activates	gene	0.65
TAUOPATHY	inhibits	gene	0.65
TNF	therapeutic_target	gene	0.65
SYNUCLEINOPATHY	inhibits	gene	0.65
ASTROCYTE	activates	gene	0.65

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (5)

Scientific analyses that reference this entity

Do physiological concentrations of SCFAs (μM range) achieve therapeutic effects

neurodegeneration | 2026-04-24 | 6 hypotheses Top: 0.670

What determines the specificity of DDR protein recruitment to dilncRNA-induced c

neurodegeneration | 2026-04-08 | 7 hypotheses

Can chaperone enhancement approaches overcome tau seed saturation effects in adv

protein folding | 2026-04-06 | 13 hypotheses Top: 0.815

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

neurodegeneration | 2026-04-03 | 43 hypotheses Top: 0.893

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

neurodegeneration | 2026-04-03 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (5)

Multi-agent debates referencing this entity

Do physiological concentrations of SCFAs (μM range) achieve therapeutic effects

closed · Rounds: 4 · Score: 0.63 · 2026-04-24

While DNAJB1 enhancement showed promise, the debate raised concerns about whethe

closed · Rounds: 4 · Score: 0.73 · 2026-04-22

While the study shows 53BP1 forms phase-separated foci driven by dilncRNAs, it's

closed · Rounds: 7 · Score: 0.95 · 2026-04-10

What gene expression changes in the aging mouse brain predict neurodegenerative

closed · Rounds: 4 · Score: 0.95 · 2026-04-03

What gene expression changes in the aging mouse brain predict neurodegenerative

closed · Rounds: 4 · Score: 0.95 · 2026-04-03

Related Research

Hypotheses and analyses mentioning SYNUCLEINOPATHY in their description or question text

No additional research found